iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.6587
-0.0378 (-5.43%)
At close: Nov 13, 2026, 4:00 PM EST
0.6589
+0.0002 (0.03%)
After-hours: Nov 13, 2026, 7:50 PM EST
iSpecimen Revenue
iSpecimen had revenue of $151.94K in the quarter ending June 30, 2026, a decrease of -78.69%. This brings the company's total for the last twelve months to $466.30K, down -92.11% year-over-year. In the year 2025, iSpecimen had annual revenue of $1.93M, down -79.24%. That makes iSpecimen the 44,633rd largest company in the world by revenue and 6,356th in the United States.
Revenue (ttm)
$466.30K
Revenue Growth
-92.11%
P/S Ratio
8.18
Revenue / Employee
$66,615
Employees
7
Market Cap
3.81M
Revenue by Geography
- Americas 1.83M 94.7%
- Europe, Middle East, and Africa (EMEA) 55.56K 2.9%
- Asia Pacific (APAC) 45.91K 2.4%
Fiscal year ended Dec 31, 2025 See the full iSpecimen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.93M | -7.36M | -79.24% |
| Dec 31, 2024 | 9.29M | -637.07K | -6.42% |
| Dec 31, 2023 | 9.93M | -474.12K | -4.56% |
| Dec 31, 2022 | 10.40M | -733.00K | -6.58% |
| Dec 31, 2021 | 11.14M | 2.95M | 36.06% |
| Dec 31, 2020 | 8.18M | 3.89M | 90.40% |
| Dec 31, 2019 | 4.30M | -96.47K | -2.20% |
| Dec 31, 2018 | 4.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MDxHealth | 114.02M |
| Biodesix | 105.21M |
| Burning Rock Biotech | 73.70M |
| Exagen | 72.30M |
| XWELL | 28.28M |
| Precipio | 27.76M |
| bioAffinity Technologies | 5.53M |
| Insight Molecular Diagnostics | 1.67M |
ISPC News
- 9 days ago - iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products - Newsfile Corp
- 15 days ago - iSpecimen Transcript: EGM 2026 - Transcripts
- 15 days ago - iSpecimen Proxy statement: Proxy filing - Filings
- 16 days ago - iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent - Newsfile Corp
- 26 days ago - iSpecimen Proxy statement: Proxy filing - Filings
- 5 weeks ago - iSpecimen Transcript: AGM 2026 - Transcripts
- 5 weeks ago - iSpecimen Proxy statement: Proxy filing - Filings
- 6 weeks ago - iSpecimen Supports Hospital Validation of New Chemistry Analyzer - Newsfile Corp